Prevalencia del COVID-19 en pacientes diabéticos en el Hospital General Docente de Riobamba durante el periodo marzo-diciembre 2020

Abstract

The aim of this research study was to determine the prevalence of COVID-19 in diabetic patients of the Hospital General Docente de Riobamba, during March-December 2020. To this purpose, a retrospective study was carried out, where 126 medical records of diabetic patients diagnosed with COVID-19 who met the inclusion and exclusion criteria, of which the following were identified: sex, age, complications, laboratory tests and pharmacological treatment. As a result of the study, it is shown that there is 22% prevalence of Diabetes Mellitus compared to other comorbidities present in patients with this virus. In addition, 99% had type II diabetes mellitus while 1% had type I diabetes mellitus. Since the first case was reported, different empirical treatments have been used based on knowledge of recognized human coronaviruses, the most used were: analgesics, corticosteroids, antidepressants, anticoagulants, antivirals and antibiotics that finished the largest number of medications, each one varied according to the patient's condition and comorbidities. It is concluded that the pandemic caused 53% mortality due to the fact that patients, in addition to diabetes, had other comorbidities, such as: high blood pressure, kidney problems, cardiovascular problems, and thyroid disorders, which conditioned their recovery. It is recommended to carry out an analysis on the rational use of medicines in these times of pandemic, reducing the problems of resistance to antibiotics.